Gelteq Limited is an Australia-based clinical and science-based company. The Company is focused on developing and commercializing white-label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products. The Company offers a complete end-to-end service for the development of new products and the conversion of existing products and formulations into gels. Its product suite consists of multiple products that sit within five core verticals - for pets, sports, pharmaceuticals (pharma), over-the-counter (OTC) and nutraceuticals. The Company’s delivery system provides pharma and nutraceutical enhancements throughout every stage of ingestion in both animals and humans, addressing the complete experience from the point of ingestion to final absorption. The Company also offers a highly versatile portfolio of pre-tested and market-ready proprietary formulations that can be white-labelled.
企業コードGELS
会社名Gelteq Ltd
上場日Oct 29, 2024
最高経営責任者「CEO」Mr. Nathan Jacob Givoni
従業員数7
証券種類Ordinary Share
決算期末Oct 29
本社所在地Level 4
都市MELBOURNE
証券取引所NASDAQ Capital Market Consolidated
国Australia
郵便番号3205
電話番号61390873990
ウェブサイトhttps://www.gelteq.com
企業コードGELS
上場日Oct 29, 2024
最高経営責任者「CEO」Mr. Nathan Jacob Givoni
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし